Medinter was established in 2001 as a joint venture and reorganized in 2006 as a Joint Limited Liability Company. The company’s annual turnover reached 10 million US$, the number of employees was 50 people, and in addition to the usual divisions – wholesale and retail, engaged in foreign economic activity, there was a full-time division for registration and clinical trials of medicines, medical devices, biological products. During the activity of the company, more than one hundred medicinal and biological preparations, diagnostic kits and medical devices manufactured in the USA, Canada, Argentina, the European Union, India, China, Korea, the Russian Federation, Ukraine, Armenia have been registered and brought to the market of the Republic of Belarus. The company owns several properties used as offices, a pharmacy, a certified warehouse for the storage of medicines and biologicals that meets the requirements of the “cold chain” with a total area of ​​more than 2000 m2. Mediinter supplied the Belarusian market with products from Novartis, Sandoz, Aventis, AstraZeneca, Vifor, Bioton, BioMarin, Solvay, Korea United Pharm, Eriochem, Bharat Serums & Vaccines, Lupin, Cipla, Gland Pharma, Macleods, Torrent, Orchid, Biosurf, Amoytop, Sciprogen, Riemser.

At present, Mediinter’s business is diversified and optimized, while we maintain Mediinter as a regional brand in international pharmaceutical distribution and continue to develop projects with the participation of our partners in various countries of the world.